- -

Combined VEGF-A and VEGFR-2 concentrations in plasma: diagnostic and prognostic implications in patients with advanced NSCLC

RiuNet: Institutional repository of the Polithecnic University of Valencia

Share/Send to

Cited by

Statistics

Combined VEGF-A and VEGFR-2 concentrations in plasma: diagnostic and prognostic implications in patients with advanced NSCLC

Show full item record

Jantus Lewintre, E.; Sanmartin, E.; Sirera Pérez, R.; Blasco, A.; Sanchez, JJ.; Taron, M.; Rosell, R.... (2011). Combined VEGF-A and VEGFR-2 concentrations in plasma: diagnostic and prognostic implications in patients with advanced NSCLC. Lung Cancer. 74(2):326-331. doi:10.1016/j.lungcan.2011.02.016

Por favor, use este identificador para citar o enlazar este ítem: http://hdl.handle.net/10251/77412

Files in this item

Item Metadata

Title: Combined VEGF-A and VEGFR-2 concentrations in plasma: diagnostic and prognostic implications in patients with advanced NSCLC
Author:
UPV Unit: Universitat Politècnica de València. Escuela Técnica Superior de Ingeniería Agronómica y del Medio Natural - Escola Tècnica Superior d'Enginyeria Agronòmica i del Medi Natural
Issued date:
Abstract:
Introduction: The vascular endothelial growth factor (VEGF) family of ligands and receptors (VEGFR) play an important role in tumor angiogenesis. Increased expression of angiogenic factors in tumors or in blood is associated ...[+]
Subjects: Advanced NSCLC , Biomarkers , Prognostic , VEGF , VEGFR-2 , Cisplatin , Docetaxel , Vasculotropin A , Vasculotropin receptor 2 , Adult , Advanced cancer , Aged , Article , Cancer combination chemotherapy , Cancer diagnosis , Enzyme linked immunosorbent assay , Female , Human , Lung non small cell cancer , Major clinical study , Male , Priority journal , Prognosis , Aged, 80 and over , Antineoplastic Combined Chemotherapy Protocols , Carcinoma, Non-Small-Cell Lung , Disease Progression , Humans , Lung Neoplasms , Middle Aged , Neoplasm Staging , Taxoids , Tumor Markers, Biological , Vascular Endothelial Growth Factor A , Vascular Endothelial Growth Factor Receptor-2
Copyrigths: Cerrado
Source:
Lung Cancer. (issn: 0169-5002 )
DOI: 10.1016/j.lungcan.2011.02.016
Publisher:
Elsevier
Publisher version: https://dx.doi.org/10.1016/j.lungcan.2011.02.016
Thanks:
This work was supported in part, by a grant [PI06/104] from Instituto de Salud Carlos III and a grant [RD06/0020/1024] from Red Tematica de Investigacion Cooperativa en Cancer (RTICC), Instituto de Salud Carlos III (ISCIII), ...[+]
Type: Artículo

This item appears in the following Collection(s)

Show full item record